Literature DB >> 3661584

Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients.

W J Simpson1, S E McKinney, J S Carruthers, M K Gospodarowicz, S B Sutcliffe, T Panzarella.   

Abstract

This report from the Canadian survey of thyroid cancer describes 1,074 patients with papillary thyroid cancer and 504 with follicular thyroid cancer followed for four to 24 years. The study groups included more patients with "advanced" disease and fewer with "early" disease than in the general population because these patients were referred to radiotherapy cancer centers, sometimes routinely, but often because referring physicians believed that certain clinical features indicated the need for additional treatment. Although this report is subject to all the problems of retrospective studies, a careful assessment of the pretreatment extent of disease combined with a long follow-up period has allowed an analysis of prognostic factors with considerable confidence. Univariate analysis of 12 possible prognostic factors (excluding treatment) demonstrated that nine of them were of statistical significance: postoperative status, age at diagnosis, extrathyroidal invasion, distant metastases, nodal involvement, differentiation, sex, tumor size, and pathologic type (in descending order of importance). Multivariate analysis was carried out using cause-specific survival rates. Independently important prognostic factors at initial treatment were age at diagnosis, extrathyroidal invasion, and degree of differentiation histologically for papillary cancers; and extrathyroidal invasion, distant metastases, primary tumor size, nodal involvement, age at diagnosis, and postoperative status for follicular cancers. The prognostic factors for tumor recurrence were quite different for the papillary and follicular cancers and ranked differently for the two groups.

Entities:  

Mesh:

Year:  1987        PMID: 3661584     DOI: 10.1016/0002-9343(87)90758-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  53 in total

Review 1.  Recurrent or persistent thyroid cancer of follicular cell origin.

Authors:  M Duren; Q Y Duh; A E Siperstein; O H Clark
Journal:  Curr Treat Options Oncol       Date:  2000-10

2.  Development of a New Clinical Severity Staging System for Patients With Nonmetastatic Papillary Thyroid Carcinoma.

Authors:  Omar A Karadaghy; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

3.  Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.

Authors:  Bin Xu; Tihana Ibrahimpasic; Laura Wang; Mona M Sabra; Jocelyn C Migliacci; R Michael Tuttle; Ian Ganly; Ronald Ghossein
Journal:  Thyroid       Date:  2016-09-07       Impact factor: 6.568

4.  Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology.

Authors:  Paul A VanderLaan; Ellen Marqusee; Jeffrey F Krane
Journal:  Cancer Cytopathol       Date:  2012-03-20       Impact factor: 5.284

5.  Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.

Authors:  Volkert B Wreesmann; Iain J Nixon; Michael Rivera; Nora Katabi; Frank Palmer; Ian Ganly; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Snehal G Patel; Ronald A Ghossein
Journal:  Thyroid       Date:  2015-03-31       Impact factor: 6.568

6.  Mortality-related factors in 1056 radioiodine-treated patients with well-differentiated thyroid cancer in southern Thailand.

Authors:  Tada Yipintsoi; Teerapon Premprabha; Alan Geater; Tanyaluck Thientunyakij; Suchitra Thongmak
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

7.  Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.

Authors:  Frederik A Verburg; Bart de Keizer; Marnix G E H Lam; J M H de Klerk; Cornelis J M Lips; Inne H M Borel-Rinkes; Johannes W van Isselt
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.352

8.  Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors.

Authors:  C S Grant; I D Hay; J J Ryan; E J Bergstralh; L M Rainwater; J R Goellner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

9.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

10.  Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.

Authors:  David L Schwartz; Mark J Lobo; K Kian Ang; William H Morrison; David I Rosenthal; Anesa Ahamad; Douglas B Evans; Gary Clayman; Steven I Sherman; Adam S Garden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-25       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.